Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129658) titled 'Tirofiban Reducing periprocedural stroke onset of IntraCranial Artery angioplaSTy: a multicenter, double-blinded, randomized, and placebo-controlled trial' on Aug. 7.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Wuxi people's Hospital
Condition:
Intracranial artery stenosis induced- ischemic stroke/transient ischemic attack
Intervention:
placebo control group:Normal saline at a dose of 0.4µg/kg/min was continuously infused for 30 minutes, followed by a maintenance dose of 0.1µg/kg/min for 23.5 hours
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrol...